TW200716164A - Vaccine compositions and methods for the treatment of urinary incontinence - Google Patents

Vaccine compositions and methods for the treatment of urinary incontinence

Info

Publication number
TW200716164A
TW200716164A TW095119259A TW95119259A TW200716164A TW 200716164 A TW200716164 A TW 200716164A TW 095119259 A TW095119259 A TW 095119259A TW 95119259 A TW95119259 A TW 95119259A TW 200716164 A TW200716164 A TW 200716164A
Authority
TW
Taiwan
Prior art keywords
urinary incontinence
treatment
methods
vaccine compositions
present
Prior art date
Application number
TW095119259A
Other languages
English (en)
Inventor
Syed Ziauddin Hashmi
Bradley John Nettleton
John Walker
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of TW200716164A publication Critical patent/TW200716164A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
TW095119259A 2005-06-01 2006-05-30 Vaccine compositions and methods for the treatment of urinary incontinence TW200716164A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68678905P 2005-06-01 2005-06-01

Publications (1)

Publication Number Publication Date
TW200716164A true TW200716164A (en) 2007-05-01

Family

ID=37072557

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095119259A TW200716164A (en) 2005-06-01 2006-05-30 Vaccine compositions and methods for the treatment of urinary incontinence

Country Status (15)

Country Link
EP (1) EP1890725A2 (zh)
JP (2) JP2008545738A (zh)
KR (1) KR20080007648A (zh)
CN (1) CN101189026A (zh)
AR (1) AR054370A1 (zh)
AU (1) AU2006253914A1 (zh)
BR (1) BRPI0611390A2 (zh)
CA (1) CA2609244A1 (zh)
MX (1) MX2007015151A (zh)
NO (1) NO20075923L (zh)
RU (1) RU2007143992A (zh)
TW (1) TW200716164A (zh)
UY (1) UY29574A1 (zh)
WO (1) WO2006129162A2 (zh)
ZA (1) ZA200710213B (zh)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2161445C (en) * 1993-04-27 2009-06-30 Anna Efim Ladd Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
AUPO776897A0 (en) * 1997-07-09 1997-07-31 Csl Limited A method of achieving production gains in livestock and agents useful for same
AUPP807399A0 (en) * 1999-01-08 1999-02-04 Csl Limited Improved immunogenic lhrh composition and methods relating thereto
EP1147212B1 (en) * 1999-02-05 2009-08-26 The University Of Melbourne T helper cell epitopes
AU2001295359A1 (en) * 2000-10-30 2002-05-15 University Of Zurich GnRH analogues for treatment of urinary incontinence
US20030144203A1 (en) * 2001-12-19 2003-07-31 Voyager Pharmaceutical Corporation Methods for slowing senescence and treating and preventing diseases associated with senescence

Also Published As

Publication number Publication date
BRPI0611390A2 (pt) 2010-09-08
AU2006253914A1 (en) 2006-12-07
JP2009137972A (ja) 2009-06-25
AR054370A1 (es) 2007-06-20
NO20075923L (no) 2007-12-18
EP1890725A2 (en) 2008-02-27
CN101189026A (zh) 2008-05-28
ZA200710213B (en) 2008-09-25
CA2609244A1 (en) 2006-12-07
WO2006129162A3 (en) 2007-02-08
KR20080007648A (ko) 2008-01-22
WO2006129162A2 (en) 2006-12-07
RU2007143992A (ru) 2009-07-20
UY29574A1 (es) 2006-12-29
MX2007015151A (es) 2008-02-15
JP2008545738A (ja) 2008-12-18

Similar Documents

Publication Publication Date Title
HK1139030A1 (en) Surgical articles for treating pelvic conditions
HK1133378A1 (en) Surgical articles for treating pelvic conditions
PH12016502092A1 (en) Antimicrobial compounds and methods of making and using the same
IL190796A0 (en) Compositions and their uses for gene therapy of bone conditions
WO2010048026A3 (en) Fibroblast growth factor receptor-3 (fgfr-3) inhibitors and methods of treatment
TW200806298A (en) Methods for modulating bladder function
TW200716106A (en) Methods for modulating bladder function
GEP20115283B (en) Pyrrolopyrimidine compounds and their uses
WO2009118662A3 (en) Methods and compositions for treating bone loss
WO2008137867A3 (en) Compositions comprising mir34 therapeutic agents for treating cancer
WO2007092622A3 (en) Compositions and methods for treating bone
HK1109638A1 (en) Dr5 antibodies and uses thereof dr5
MY166546A (en) Adoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
WO2009102452A3 (en) Compositions and methods for implantation of adipose tissue and adipose tissue products
WO2006084166A3 (en) Surgical implants and related methods and systems
UA90048C2 (ru) Кондиционированная композиция и способ ее получения
TW200806325A (en) Therapeutic uses of inhibitors of RTP801
WO2009079585A3 (en) Compositions and methods for treating osteolytic disorders comprising mmp-14 binding proteins
MY176900A (en) Antimicrobial compounds and methods of making and using the same
MX2009003911A (es) Formulaciones de liberacion inmediata, mejoradas de topiramato.
TW200716088A (en) Formulations and methods for treating amyloidosis
MX2010009743A (es) Uso de derivados de pirimidina para el tratamiento de las enfermedades dependientes de los receptores del factor de crecimiento epidermico (egfr) o de enfermedades que hayan adquirido resistencia a los agentes que se dirigen a los miembros de la fami
PH12015502375B1 (en) Antimicrobial compounds and methods of making and using the same
MX2008015775A (es) Compuestos y composiciones para tratamiento de cancer.
MX2010008326A (es) Metodo y composiciones capaces de provocar un silenciamiento post-transcripcional de la expresion genica de forma sinergica.